7-benzyl-5-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-amine

ID: ALA1095424

PubChem CID: 46887765

Max Phase: Preclinical

Molecular Formula: C20H24N6

Molecular Weight: 348.45

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1n[nH]c2nc(N3CCCC3)c3c(c12)CCN(Cc1ccccc1)C3

Standard InChI:  InChI=1S/C20H24N6/c21-18-17-15-8-11-25(12-14-6-2-1-3-7-14)13-16(15)20(22-19(17)24-23-18)26-9-4-5-10-26/h1-3,6-7H,4-5,8-13H2,(H3,21,22,23,24)

Standard InChI Key:  LDIBYHVHPKHRLT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 30  0  0  0  0  0  0  0  0999 V2000
    5.4615   -1.9613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1765   -2.3742    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8903   -1.1300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8906   -1.9613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6813   -2.2179    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1698   -1.5453    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6809   -0.8729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9356   -0.0880    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7478   -2.3749    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4627   -1.1336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1739   -0.7186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1701    0.1002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4567    0.5104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7455    0.0953    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7477   -0.7298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0294    0.5054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0264    1.3306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7392    1.7422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7366    2.5666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0199    2.9776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3044    2.5579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3105    1.7348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9926   -2.0444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4417   -2.6584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8554   -3.3722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6620   -3.1992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  5  1  0
  5  6  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
  6  7  2  0
 14 16  1  0
  7  3  1  0
 16 17  1  0
  3  4  1  0
 17 18  2  0
  7  8  1  0
 18 19  1  0
 10  1  2  0
 19 20  2  0
  1  9  1  0
 20 21  1  0
 10 11  1  0
 21 22  2  0
 22 17  1  0
  9 23  1  0
  1  2  1  0
  2  4  2  0
  3 11  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26  9  1  0
M  END

Associated Targets(Human)

BRS3 Tchem Bombesin receptor subtype-3 (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Brs3 Bombesin receptor subtype-3 (78 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 348.45Molecular Weight (Monoisotopic): 348.2062AlogP: 2.70#Rotatable Bonds: 3
Polar Surface Area: 74.07Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.06CX LogP: 3.03CX LogD: 3.01
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -1.19

References

1. Guo C, Guzzo PR, Hadden M, Sargent BJ, Yet L, Kan Y, Palyha O, Kelly TM, Guan X, Rosko K, Gagen K, Metzger JM, Dragovic J, Lyons K, Lin LS, Nargund RP..  (2010)  Synthesis of 7-benzyl-5-(piperidin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-ylamine and its analogs as bombesin receptor subtype-3 agonists.,  20  (9): [PMID:20371178] [10.1016/j.bmcl.2010.03.065]

Source